Revive Therapeutics Explores the Use of Bucillamine as a Novel Treatment for Infectious Diseases including COVID-19

by NASDAQ Market News March 20, 2020

NASDAQ Market News
Click here to email author

SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19)

Press release Oncology Venture receives feedback from U.S. FDA on potential approval pathway for Dovitinib.

Ads